blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2680831

EP2680831 - TREATMENT OF ARTERIAL AGEING BY RAAS INHIBITOR [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  25.03.2016
Database last updated on 26.06.2024
Most recent event   Tooltip25.03.2016Application deemed to be withdrawnpublished on 27.04.2016  [2016/17]
Applicant(s)For all designated states
Artskin D.O.O.
Obrtna cona Logatec 30
1370 Logatec / SI
[2014/17]
Former [2014/02]For all designated states
Farmicom Pharmaceutical Company D.O.O.
Obrtna Cona Logatec 30
1370 Logatec / SI
Inventor(s)01 / SABOVIC, Miso
Ulica Bratov Ucakar 46
1000 Ljubljana / SI
 [2014/02]
Representative(s)Latzel, Klaus
Latzel-IP
Traunstrasse 3
81825 München / DE
[N/P]
Former [2014/02]Latzel, Klaus
Latzel-IP Traunstrasse 3
81825 München / DE
Application number, filing date12706831.028.02.2012
WO2012EP53378
Priority number, dateSI201100456P09.12.2011         Original published format: SI 201100456 P
SI201100060P28.02.2011         Original published format: SI 201100060 P
[2014/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012116996
Date:07.09.2012
Language:EN
[2012/36]
Type: A1 Application with search report 
No.:EP2680831
Date:08.01.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 07.09.2012 takes the place of the publication of the European patent application.
[2014/02]
Search report(s)International search report - published on:EP07.09.2012
ClassificationIPC:A61K31/122, A61K31/366, A61K31/4015, A61K31/405, A61K31/41, A61K31/415, A61K31/4155, A61K31/416, A61K31/422, A61K31/44, A61K31/47, A61K31/505, A61K31/616, A61P9/10, A61P9/14
[2014/02]
CPC:
A61K31/122 (EP); A61K31/366 (EP); A61K31/4015 (EP);
A61K31/405 (EP); A61K31/41 (EP); A61K31/415 (EP);
A61K31/4155 (EP); A61K31/416 (EP); A61K31/422 (EP);
A61K31/44 (EP); A61K31/505 (EP); A61K31/616 (EP);
A61K45/06 (EP); A61P9/10 (EP); A61P9/14 (EP) (-)
C-Set:
A61K31/122, A61K2300/00 (EP);
A61K31/4155, A61K2300/00 (EP);
A61K31/415, A61K2300/00 (EP);
A61K31/416, A61K2300/00 (EP);
A61K31/41, A61K2300/00 (EP);
A61K31/422, A61K2300/00 (EP);
A61K31/616, A61K2300/00 (EP)
(-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/02]
Extension statesBA24.09.2013
ME24.09.2013
TitleGerman:BEHANDLUNG VON ARTERIELLER ALTERUNG MITTELS RAAS-INHIBITOR[2014/02]
English:TREATMENT OF ARTERIAL AGEING BY RAAS INHIBITOR[2014/02]
French:TRAITEMENT DU VIEILLISSEMENT ARTÉRIEL PAR L'INHIBITEUR DE RAAS[2014/02]
Entry into regional phase24.09.2013National basic fee paid 
24.09.2013Designation fee(s) paid 
24.09.2013Examination fee paid 
Examination procedure24.09.2013Examination requested  [2014/02]
16.04.2014Amendment by applicant (claims and/or description)
06.05.2015Despatch of a communication from the examining division (Time limit: M06)
17.11.2015Application deemed to be withdrawn, date of legal effect  [2016/17]
16.12.2015Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2016/17]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  06.05.2015
Fees paidRenewal fee
28.02.2014Renewal fee patent year 03
02.03.2015Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XI]WO2006105806  (SABOVIC MISO [SI]) [X] 1-11,18-29,57-65,68,72-78 * page 2, paragraph 3 * * page 4, paragraphs 3-4 - page 5, paragraph 1 * * page 10, paragraphs 1, 4; example 1; claims 1-15 * [I] 1-65,68,72-78;
 [XI]US2003049314  (LIANG MATTHEW H [US], et al) [X] 2-11,18-29,57-65,68,72-78 * the whole document * [I] 1-65,68,72-78;
 [I]  - LIU LING ET AL, "Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension.", JOURNAL OF CARDIOVASCULAR PHARMACOLOGY JUL 2007 LNKD- PUBMED:17666915, (200707), vol. 50, no. 1, ISSN 0160-2446, pages 50 - 55, XP002676083 [I] 1-56,75-78 * the whole document *

DOI:   http://dx.doi.org/10.1097/FJC.0b013e31805751d3
 [I]  - KOH K K ET AL, "Combination therapy for treatment or prevention of atherosclerosis: Focus on the lipid-RAAS interaction", ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, IE, vol. 209, no. 2, ISSN 0021-9150, (20100401), pages 307 - 313, (20090912), XP026982278 [I] 1-56,75-78 * the whole document *
by applicantWO2005072696
 WO2006105806
    - MITCHELL GF ET AL., "Arterial stiffness and cardiovascular events: The Framingham Heart Study", CIRCULATION, (2010), vol. 121, pages 505 - 11
    - NAJJAR S. S. ET AL., ARTERIAL AGING, HYPERTENSION, (2005), vol. 46, pages 454 - 462
    - "Atherosclerosis and aging of the arterial wall", CAN MED ASSOC J, (1992), vol. 147, no. 2, page 201
    - H.-Y. LEE ET AL., CIRCULATION JOURNAL, (2010), vol. 94, pages 2258 - 2262
    - ANTONPOULOS AA ET AL., RECENT PAT CARDIOVASC DRUG DISC, (2009), vol. 4, pages 76 - 87
    - "The third report of the National Cholesterol Education Program (NCEP) Expert panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III", CIRCULATION, (2002), vol. 106, pages 3143 - 3421
    - ANDERSON KM ET AL., "An updated coronary risk profile. A statement for health professionals", CIRCULATION, (1991), vol. 83, pages 356 - 362
    - CORRETTI MC ET AL., "Guidelines for the ultrasound assessment of endothelial- dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force", J AM COLL CARDIOL, (2002), vol. 39, pages 257 - 65, XP002591839
    - JURASIC MJ ET AL., "Beta stiffness - setting age standards", ACTA CLIN CROAT, (2009), vol. 48, pages 253 - 8
    - CARERJ S., "Normal vascular ageing evaluated by a new tool: e-tracking", EUR J ECHOCARDIOGRAPHY, (2006), no. 1, page 49
    - CARERJ S ET AL., EUR J ECHOCARDIOGRAPHY, (2006), page 49
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.